Margaret Wooddell, PhD, MBA

Daiichi Sankyo, Inc.
Basking Ridge, New Jersey, United States

Disclosure information not submitted.

Presentation(s):

• Paper 28 - A PHASE 4, MULTICENTER, GLOBAL CLINICAL TRIAL TO EVALUATE DISCONTINUATION AND RECHALLENGE OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR PREVIOUSLY TREATED WITH PEXIDARTINIB

  Thursday, November 2, 2023
  4:00 PM – 5:30 PM